Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Biotechnology Transfer & Commercialization Conference

24 Oct 2012 - 26 Oct 2012 - Philadelphia, PA, USA



Bookmark and Share


Leading innovations in biotech advancement and discovery are found within academic institutions and emerging companies. These organizations play an increasingly important role in developing new drug therapies for the treatment of diseases ranging from Alzheimer’s to cancer to cystic fibrosis to HIV/AIDS and many others. A gulf exists between early research and commercial drug development. The next steps in drug advancements are both challenging and expensive including advanced clinical trials up to the marketing of successful therapies, requiring significant investments. An era of biotech business paradigm shifts requires a new understanding among the various market segments.Bridging the gulf requires a dialogue among academic, investment and commercial organizations. GTC’s Biotechnology Transfer & Commercialization Conference will bring together the players needed to move the industry forward. Leading universities, pharmaceutical companies, venture capital, foundations and biotech companies will come together to share their perspectives, discuss new models of cooperation and develop the business relationships that get deals done. Together they will create new technologies, new companies and new medicines.



Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!